Background: Antimicrobial prescribing is frequently reported as appropriate or inappropriate, particularly in the ICU. However, the definitions used are non-standardized and lack validity and reliability.
Introduction
Sepsis and infection-related complications are common in critically ill patients and a common cause of mortality. 1 Up to 30% of ICU patients develop a nosocomial infection and 70% receive antimicrobials during their admission. 2 Antimicrobial resistance among nosocomial ICU infections is reported as high as 70% and antimicrobial use is considered a primary driver of drug resistance. 3 Diagnostic challenges and imprecise infection resolution endpoints contribute to potentially inappropriate antimicrobial use. 3 Valid and reliable antimicrobial prescribing appropriateness definitions that balance effective and safe therapy with potentially harmful unnecessary use could help guide antimicrobial stewardship efforts, such as point prevalence audits and scorecards of prescribing appropriateness.
Spivak et al. 4 reviewed definitions and measures of appropriate antimicrobial prescribing, including 25 studies in the acute care setting. In 13 studies, 'expert opinion' was the criterion used to derive the definition of appropriateness, while 2 studies combined expert opinion with local antimicrobial prescribing guidelines and 1 study combined expert opinion with in vitro susceptibility results. The authors concluded that current definitions are unable to discriminate appropriateness of antimicrobial therapy due to a lack of clinical assessment (i.e. reliance solely on susceptibility data) and that expert opinion alone suffers from a lack of objectivity and external validity. The authors encourage further assessment and development of evaluation or audit tools to assess prescribing practices. Similarly, recognizing existing limitations to defining appropriate antimicrobial prescribing, our antimicrobial stewardship programme (ASP) sought to develop valid and reliable appropriateness criteria for antimicrobial prescribing in the ICU. These criteria will allow regular performance feedback to prescribers, which has face validity and reliability and is sufficiently granular to be considered meaningful by clinicians.
The RAND/UCLA Appropriateness Method (RAM) is a widely used approach to categorizing appropriateness of medical interventions, using 'appropriate', 'uncertain' and 'inappropriate'. 5 However, this methodology is unable to differentiate the nuances of appropriateness in antimicrobial prescribing, such as a treatment being effective but unnecessary. We used the RAM methodology while modifying the RAM categories to better facilitate auditing of antimicrobial prescribing appropriateness.
Methods
We used the consensus-based modified Delphi method, a structured, systematic approach previously used to develop quality indicators for antimicrobial stewardship metrics and antimicrobial therapy appropriateness in sepsis. 6, 7 To address the challenges associated with applying the categories of 'uncertain' and 'inappropriate' to antimicrobial prescribing, we proposed the following three categories instead: 'appropriate but unnecessary', 'inappropriate and under-treatment' and 'inappropriate and unnecessary'. We proposed criteria for each category, based on widely recognized principles of antimicrobial prescribing. 8, 9 Modified Delphi panel process overview First questionnaire round and expert panel assembly
The expert panel comprised clinicians involved in direct patient care in one of four ICUs, at three different academic hospitals within our ASP scope. ICU 1 is a 16 bed unit in a 472 bed tertiary care general hospital, which also serves a cancer centre. ICU 2 is a 23 bed unit in a 471 bed tertiary care centre where solid organ transplant recipients account for nearly 40% of ICU bed occupancy. ICU 3 is a 20 bed cardiovascular unit at the same site. ICU 4 is a 24 bed unit in a 256 bed tertiary care centre with neurosurgery and neurology patients accounting for 40% of bed occupancy.
We made extensive efforts to include all important stakeholder groups, including asking programme and ICU leaders to identify potential panel participants. Invitations to participate in the consensus process were extended to all intensivists (25), ICU pharmacists (13), infectious diseases physicians (21) and physician and surgeon leaders frequently involved in the care of patients in the ICUs (e.g. transplant surgeons and internists, vascular surgeons) (5). The consensus process was conducted from November 2015 to March 2016. Members of the ASP team (i.e. infectious diseases physicians and infectious diseases pharmacists) were excluded from the consensus process. ASP team members were involved in the project team, which developed the draft criteria and assisted the facilitator during the expert panel meeting. It was felt that ASP team members would be biased in their adjudication of the proposed criteria.
The expert panel was given access to an electronic version of the definitions and ranked the criteria on a five-point Likert scale from 'strongly agree' to 'strongly disagree'. Panel members were asked to provide any modifications or suggest new criteria for consideration.
The results of the first questionnaire round were analysed and criteria with an overall rating by all responding experts as 'strongly agree' or 'agree' were considered to have face validity and reliability. Disagreement was defined as any item that did not have agreement by raters as stated above.
Consensus meeting
The definitions and survey results were presented at an in-person meeting of the expert panel facilitated by a general internist with expertise in healthcare quality. The experts were asked to re-rate the definitions to give opportunity to change ratings based on the explanation provided by the facilitator and to allow anyone that had not completed a rating prior to the meeting an opportunity to do so. Panel members then applied the definitions to a series of clinical scenarios presented by the facilitator. Panel responses were immediately recorded and presented, and then further discussion was invited. All clinicians that were initially invited to participate, but could not commit to the expert panel, were provided with the definitions and clinical scenarios via SurveyMonkey V R and asked to rate the criteria and categorize the case scenarios using those definitions. This attempted to replicate the in-person meeting process.
The definitions were revised based on discussion from the expert panel and online survey, and were recirculated for re-rating by the expert panel and online participants using the same determination of acceptance as in the first questionnaire round.
Results

Definitions
Based on accepted principles of antimicrobial prescribing, seven criteria for 'appropriate', five criteria for 'appropriate but unnecessary', three criteria for 'inappropriate and unnecessary' and seven criteria for 'inappropriate and under-treatment' were proposed (total 22). 8, 9 First questionnaire round and expert panel assembly
Of the 64 experts invited to participate 22 (34%) accepted: 10 intensivists, 3 infectious diseases physicians, 5 ICU pharmacists and 4 sub-specialty experts. Fourteen of the 22 experts returned the firstround questionnaire (64% response rate). A total of 20 of the original 22 (91%) criteria were considered reliable and valid. There was disagreement among responses for two criteria regarding unnecessary treatment: one defining the role of double coverage and one defining parenteral versus enteral route appropriateness.
Eight additional experts participated through the online survey and results were similar to those of the expert panel.
Consensus meeting
Upon conclusion of the consensus meeting, all 20 of the criteria that originally met standards for acceptance were still considered valid and reliable (with minor revisions). The two criteria that initially demonstrated disagreement were amended for consideration in the next round. One additional criterion was proposed and none was deleted (total 23).
Additionally, the categories were revised as follows: 'appropriate', 'effective but unnecessary', 'inappropriate' and 'under-treatment'. The 14 experts (64% response rate) that responded to the second round of rating accepted all the amended definitions (Table 1) .
A post-meeting survey found unanimous agreement among participants that their opinions were valued, that the process was fair and that no one altered their responses or opinions due to feeling intimidated.
Discussion
Use of a modified Delphi process with an inter-professional panel of clinical experts resulted in consensus agreement for 23 criteria in four distinct categories (appropriate, effective but unnecessary, inappropriate, and under-treatment) defining appropriateness of antimicrobial therapy in critical care.
Our proposed categories and criteria have several strengths. First, we invited multidisciplinary input to ensure the definitions would have face validity and be accepted widely. We used a modified Delphi process to arrive at consensus. This is an established method of combining evidence with expert opinion in a structured Antimicrobial prescribing appropriateness in the ICU JAC and objective manner. 6 Achieving consensus with our definitions suggests that the process led to the desired result.
Our process carries some limitations. Panel participants were identified from our own academic institutions. Some participants, therefore, through exposure to our ASP may be biased towards more conservative use of antimicrobials. Additionally, although efforts were made to choose panelists with a wide range of clinical practice patterns, it is possible that respondents may have selfselected to support our own biases. An in-person meeting as part of the Delphi process is common practice, but is vulnerable to social influences that blinded panels avoid. 6 Our post-meeting survey and the consistency with online survey results suggests that this was not a significant problem with our panel.
Recognizing the current lack of definitions for appropriate antimicrobial prescribing that are both objective and discriminatory, Spivak et al. 4 proposed standardized nomenclature. We are also proposing standardized criteria, but have used an accepted structured methodology to arrive at consensus and have tested them for applicability. Of note, panel members found that the RAND categories 'appropriate but unnecessary', 'inappropriate and unnecessary' and 'inappropriate and under-treatment' did not capture the nuances of antimicrobial prescribing. As an example, Dresser et al.
the expert panel was not comfortable using the term 'appropriate but unnecessary' to describe prescribing that could potentially cause patient harm or that was deemed suboptimal (e.g. vancomycin for MSSA in the absence of contraindications). Therefore we changed the terminology to 'effective but unnecessary', 'inappropriate' and 'under-treatment', novel terms that have not been externally validated, but were readily accepted by our panel.
We deliberately avoided including guidelines in our definitions, although our criteria do not preclude the use of such guidelines. National infectious diseases guidelines are frequently based on expert opinion, may not follow accepted evidence-based methods for development and might not exist in all jurisdictions. 10 Updates often lag behind important changes in antimicrobial resistance, limiting applicability to a clinician's own practice.
Standardized, broadly accepted definitions for appropriate antimicrobial prescribing are essential to reliably measure the impact of antimicrobial stewardship interventions. Collective work in this area will lead to more reliable and valid assessment of prescribing in critical care, as well as other patient populations and practice settings.
